![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZTA9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--d0271a502fc7f576c99319276ad702f621253a0e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Protagonist-website.fw_.png)
Protagonist Therapeutics
Protagonist Therapeutics discovers and develops novel stable peptide therapies for autoimmune disorders.
Website
www.protagonist-inc.comPartner
Julie GrantInvestment
Series C
Protagonist Therapeutics discovers and develops novel stable peptide therapies for autoimmune disorders.
Series C